These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31432177)

  • 1. Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways.
    Zhang L; Tao X; Fu Q; Ge C; Li R; Li Z; Zhu Y; Tian H; Li Q; Liu M; Hu H; Zeng B; Lin Z; Li C; Luo R; Song X
    Oncol Rep; 2019 Nov; 42(5):1843-1855. PubMed ID: 31432177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of daphnetin on the mechanism of epithelial-mesenchymal transition induced by HMGB1 in human lung adenocarcinoma cells (A549 cell line).
    Gong SQ; Liu H; Wu JL; Xu JX
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1489-1510. PubMed ID: 36994673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
    Baharuddin P; Satar N; Fakiruddin KS; Zakaria N; Lim MN; Yusoff NM; Zakaria Z; Yahaya BH
    Oncol Rep; 2016 Jan; 35(1):13-25. PubMed ID: 26531053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Inhibits the Migration and Invasion of Non-Small-Cell Lung Cancer Cells Through Radiation-Induced Suppression of Epithelial-Mesenchymal Transition and Soluble E-Cadherin Expression.
    Deng X; Chen C; Wu F; Qiu L; Ke Q; Sun R; Duan Q; Luo M; Luo Z
    Technol Cancer Res Treat; 2020; 19():1533033820947485. PubMed ID: 33124505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR.
    Lan L; Wang H; Yang R; Liu F; Bi Q; Wang S; Wei X; Yan H; Su R
    Life Sci; 2019 Oct; 234():116742. PubMed ID: 31401315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
    Pan Y; Sun Y; Liu Z; Zhang C
    Mol Med Rep; 2020 Aug; 22(2):1594-1604. PubMed ID: 32626956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.
    Chen QY; Jiao DM; Wang LF; Wang L; Hu HZ; Song J; Yan J; Wu LJ; Shi JG
    Mol Biosyst; 2015 Mar; 11(3):859-68. PubMed ID: 25578635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
    Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
    Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cells.
    Aedo-Aguilera V; Carrillo-Beltrán D; Calaf GM; Muñoz JP; Guerrero N; Osorio JC; Tapia JC; León O; Contreras HR; Aguayo F
    Oncol Rep; 2019 Nov; 42(5):2139-2148. PubMed ID: 31436299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cells.
    Wang C; Song X; Shang M; Zou W; Zhang M; Wei H; Shao H
    Future Oncol; 2019 Apr; 15(11):1243-1253. PubMed ID: 30843426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.
    Liu B; Wang Z; Cheng S; Du L; Yin Y; Yang Z; Zhou J
    Mol Med Rep; 2019 Aug; 20(2):1418-1428. PubMed ID: 31173238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells.
    Yin J; Zhang H; Wu X; Zhang Y; Li J; Shen J; Zhao Y; Xiao Z; Lu L; Huang C; Zhang Z; Du F; Wu Y; Kaboli PJ; Cho CH; Yuan D; Li M
    Int J Mol Med; 2020 Jun; 45(6):1783-1792. PubMed ID: 32236608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
    Yang N; Liang Y; Yang P; Ji F
    Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
    Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
    Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway.
    Tsai JR; Liu PL; Chen YH; Chou SH; Cheng YJ; Hwang JJ; Chong IW
    PLoS One; 2015; 10(12):e0144462. PubMed ID: 26656720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.